Immunomodulatory effects of RXR rexinoids: Modulation of high-affinity IL-2R expression enhances susceptibility to denileukin diftitox

Blood

Volumn 100, Issue 4, 2002, Pages 1399-1403

  Gorgun, Gullu ^a   Foss, Francine ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; BEXAROTENE; DENILEUKIN DIFTITOX; INTERLEUKIN 2 RECEPTOR; PROTEIN P55; PROTEIN P75; RETINOIC ACID RECEPTOR; RETINOID X RECEPTOR;

ANTINEOPLASTIC ACTIVITY; ARTICLE; AUTOIMMUNE DISEASE; B CELL LEUKEMIA; CONTROLLED STUDY; CYTOTOXICITY; DRUG SENSITIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOMODULATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR AFFINITY; T CELL LEUKEMIA;

EID: 0037103316     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0300     Document Type: Article

References (31)

1. Nuclear receptor that identifies a novel retinoic acid response pathway
2. Retinoid X receptor alpha and retinoic acid receptor gamma mediate expression of genes encoding tight-junction proteins and barrier function in F9 cells during visceral endodermal differentiation
3. Retinoids: Present role and future potential
4. Retinoids increase human apo C-III expression at the transcriptional level via the retinoid X receptor. Contribution to the hypertriglyceridemic action of retinoids
5. Upregulation by retinoic acid of interleukin-2-receptor mRNA in human T lymphocytes
6. Activation-induced down-regulation of retinoid receptor RXRalpha expression in human T lymphocytes. Role of cell cycle regulation
7. Retinoic acids regulate apoptosis of T lymphocytes through an interplay between RAR and RXR receptors
8. Retinoic acid-induced modulation of IL-2 mRNA production and IL-2 receptor expression on T cells
9. Antitumor activity of DAB389IL-2 fusion toxin in mycosis fungoides
10. Phase I trial of a ligand fusion-protein (DAB389IL-2) in lymphomas expressing the receptor for interleukin-2
11. T-cell lymphoma cell lines (HUT102 and HUT78) established at the National Cancer Institute: History and importance to understanding the biology, clinical features, and therapy of cutaneous T-cell lymphomas (CTCL) and adult T-cell leukemia-lymphomas (ATLL)
12. Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation
13. Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL)
14. Interieukin 2 (IL-2) receptor expression and sensitivity to diphtheria fusion toxin DAB389IL-2 in cultured hematopoietic cells
15. Retinoid regulation of interleukin-2 receptors on human T-cells
16. All-transretinoic acid modulates expression levels of thyroglobulin and cytokines in a new human poorly differentiated papillary thyroid carcinoma cell line, KTC-1
17. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes
18. Molecular cloning and expression of cDNAs for the human interieukin-2 receptor
19. Interleukin 2 receptor gene expression in normal human T lymphocytes
20. The IL-2 receptor complex: Its structure, function, and target genes
21. Signaling from the IL-2 receptor to the nucleus
22. DAB389IL-2 (ONTAK): A novel fusion toxin therapy for lymphoma
23. DAB389IL-2 (denileukin diftitox, ON-TAK): A new fusion protein technology
24. Cloning of the gamma chain of the human IL-2 receptor
25. Demonstration of a non-Tac peptide that binds interleukin 2: A potential participant in a multichain interleukin 2 receptor complex
26. The human interleukin-2 receptor beta-chain gene: Genomic organization, promoter analysis and chromosomal assignment
27. Interleukin 2 receptor-targeted cytotoxicity: Interleukin 2 receptor-mediated action of a diphtheria toxin-related interleukin 2 fusion protein
28. Distribution of lymphocytes with interleukin-2 receptors (TAC antigens) in reactive lymphoproliferative processes, Hodgkin's disease, and non-Hodgkin's lymphomas: An immunohistologic study of 300 cases
29. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes
30. Alltrans retinoic acid inhibition of anti-CD3-induced T cell apoptosis in human immunodeficiency virus infection mostly concerns CD4 T lymphocytes and is mediated via regulation of CD95 ligand expression
31. Inhibition of activation-induced apoptosis of thymocytes by all-trans- and 9-cis-retinoic acid is mediated via retinoic acid receptor alpha